Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues-Reference-Cited by-同舟云学术

Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues

Published:2009-08-25 Issue:1 Volume:51 Page:73-80
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

van Bömmel Florian,de Man Robert A.,Wedemeyer Heiner,Deterding Katja,Petersen Jörg,Buggisch Peter,Erhardt Andreas,Hüppe Dietrich,Stein Kerstin,Trojan Jörg,Sarrazin Christoph,Böcher Wulf O.,Spengler Ulrich,Wasmuth Hermann E.,Reinders Jurrien G.P.,Möller Bernd,Rhode Peter,Feucht Heinz-Hubert,Wiedenmann Bertram,Berg Thomas

Publisher

Wiley

Subject

Hepatology

Reference24 articles.

1. Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine;Lampertico;HEPATOLOGY,2005

2. Acyclic nucleoside phosphonates: a key class of antiviral drugs;De Clercq;Nat Rev Drug Discov,2005

3. Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication;van Bömmel;HEPATOLOGY,2002

4. Activity of tenofovir on hepatitis B virus replication in HIV co-infected patients failing or partially responding to lamivudine;Núñez;AIDS,2002

5. Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus;Benhamou;N Engl J Med,2003

Cited by 307 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution and diversity of the hepatitis B virus genome: Clinical implications;Virology;2024-10

2. Risk Factors for Development of Cirrhosis in Chronic Viral Hepatitis B Patients Who Had Persistent Viral Suppression With Antiviral Therapy;Journal of Clinical and Experimental Hepatology;2024-07

3. Kinetics of the hepatitis B core‐related antigen and treatment responses in chronic hepatitis B patients treated with tenofovir alafenamide;Hepatology Research;2024-04-29

4. Identification and assessment of the 1,6-dihydroxy-pyridin-2-one moiety as privileged scaffold for HBV ribonuclease H inhibition;Antiviral Research;2024-03

5. Antiviral Evaluation of Dispirotripiperazines against Hepatitis B Virus;Journal of Medicinal Chemistry;2023-08-23